UnitedHealth Group Stock Performance
UnitedHealth Group shares closed at $349.91, declining 1.02% in the most recent session and trading well below key technical thresholds, per SID market data. The stock sits beneath both its 50-day moving average of $391.50 and its 200-day moving average of $367.84, indicating sustained downward pressure across multiple timeframes. Over the trailing one-month period, UNH has declined 4.23%, though the three-month return is marginally positive at 0.28%, and the one-year return stands at 16.34%. The 14-day relative strength index reads 39.5, approaching oversold territory but not yet triggering a classic oversold signal below 30. According to Massive/Polygon data, average daily trading volume is approximately 8.77 million shares. UNH carries a beta of 0.432, reflecting significantly lower volatility than the broader market. The company's market capitalization currently stands at approximately $305 billion, maintaining its position as the largest publicly traded healthcare company.
UnitedHealth Group Valuation Analysis
UnitedHealth Group currently trades at a price-to-earnings ratio of 17.38, per SID market data, which remains moderate relative to the broader healthcare sector. The stock's price-to-book ratio stands at 3.19, according to SEC filings, reflecting the company's significant intangible asset base from acquisitions across its Optum and UnitedHealthcare segments. The PEG ratio registers at negative 1.02, a figure driven by recent earnings growth trajectory disruptions that have distorted forward growth estimates. UNH offers a dividend yield of approximately 2.59%, providing income-oriented investors with a meaningful yield above the S&P 500 average. The current valuation represents a compression from historical premium multiples the stock has commanded, as the share price at $349.91 has pulled back while trailing earnings remain intact. The combination of a sub-20 P/E and above-average dividend yield positions UNH at the lower end of its historical valuation range within the managed care industry.
Smart Money Activity for UNH
UnitedHealth Group's composite smart money score stands at 41 out of 100, registering a neutral signal according to SID market data. The institutional component scores a perfect 25 out of 25, reflecting maximum conviction from large fund managers who continue to maintain or increase positions, per 13F institutional filings. In contrast, the insider score registers at 0 out of 25, despite notable recent filing activity. SEC Form 4 filings reveal 20 insider transactions over the past 90 days, with 19 purchases and only 1 sale, a heavily skewed buy-to-sell ratio that suggests corporate insiders view current price levels as attractive. The dark pool activity score sits at 12.2 out of 25, indicating moderate levels of off-exchange institutional trading. Congressional trading activity registers at 4.0 out of 25, showing minimal legislative portfolio adjustments involving UNH. The divergence between strong institutional ownership signals and the low composite score reflects mixed signals across the remaining smart money sub-categories, warranting close monitoring of future filing disclosures.
UnitedHealth Group Earnings Outlook
UnitedHealth Group has delivered consistent earnings beats across its three most recently reported quarters, according to company earnings reports. In the most recent quarter reported on April 21, 2026, UNH posted earnings per share of $7.23 against analyst estimates of $6.56, representing a positive surprise of $0.67. The prior quarter saw an even larger beat, with actual EPS of $6.38 versus the $4.85 consensus estimate, delivering a $1.53 upside surprise. The quarter reported on October 13 also exceeded expectations, with $4.69 in actual EPS compared to the $4.14 estimate, a $0.55 beat. Looking ahead, the next earnings report is scheduled for October 27, 2026, with analyst estimates currently set at $4.14 per share. The trailing three-quarter pattern of outperformance, averaging a positive surprise of approximately $0.92, establishes a track record of execution above consensus expectations across both the Optum and UnitedHealthcare segments.
Wall Street Analyst Ratings for UNH
Wall Street consensus on UnitedHealth Group remains uniformly positive, with all five most recent analyst actions maintaining bullish ratings, per SID consensus data. On October 27, 2026, both Wells Fargo and Morgan Stanley reiterated their Overweight ratings on UNH, signaling continued conviction despite recent share price weakness. Mizuho maintained its Outperform rating on October 22, while RBC Capital reiterated Outperform on October 20, according to Wall Street analyst reports. JP Morgan also sustained its Overweight designation on October 16. Notably, none of these five actions involved a downgrade or a shift from a prior rating, as each firm carried forward its existing bullish stance. The clustering of reaffirmations within an 11-day window in late October suggests coordinated reassessment likely tied to quarterly earnings results and updated guidance. With zero neutral or negative ratings among recent coverage actions, the analyst community maintains a consensus that UNH shares are positioned for appreciation from current levels near $349.91.